Pipeline

We build a world-class pipeline by proprietary discovery platforms. Our innovation engine has been validated by clinical assets and global partnerships.

Get in Touch →

You are here: Home » Pipeline » PHASE 2

PHASE 3
PHASE 2
PHASE 1
PRE-CLINICAL

PHASE 2

BSI-992/902

Target / Modality: TROP2-ADC
Indication: Gastric cancer/Cholangiocarcinoma
Status: Phase 1/2
Partner(territory right): OBI Pharma (Global ex-China)

Find us in China, Hong Kong SAR, the United States & Australia

Quick Links

- BD@Biosion.com
- +1-302-998-5126
- +86-25-5829-1977